Pharmaceuticals, Biotechnology and Life Sciences
NAARDEN, Netherlands & HERZLIYA, Israel–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative…
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Diana McKenzie has been appointed to its board of directors as…
– European approval is based on the Phase 3 BEACON CRC trial that demonstrated a significant improvement in overall survival…
Octapharma USA Extends Funding for COVID-19 Study Following Positive Preliminary Research Data
Revita T2Di pivotal study to evaluate the ability of Revita DMR, the first non-drug, non-surgical, disease-modifying therapy, to eliminate need…
SAN DIEGO–(BUSINESS WIRE)–#DMT–CB Therapeutics, Inc. has achieved the first successful biosynthesis of DMT (N,N Dimethyltryptamine) and related tryptamine-based compounds in…
On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC) assay for endotoxin detection in parenteral pharmaceuticals and implantable medical devices.
Company Expands Product Portfolio with Next Generation Product Candidate Anticipated in 2022 ROSEVILLE, Minn.–(BUSINESS WIRE)–Calyxt, Inc. (NASDAQ: CLXT), a plant-based…
Evotec licenses novel polycystic ovary syndrome target identified by Celmatix through its Reproductive Atlas™ platform to Bayer NEW YORK–(BUSINESS WIRE)–Celmatix…
